Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer

Persistent symptomatic coronavirus disease 2019 (COVID-19) is a distinct clinical entity among patients with hematologic cancer and/or profound immunosuppression. The optimal medical management is unknown. We describe 2 patients who had symptomatic COVID-19 for almost 6 months and were successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Catherine, Yoke, Leah H, Bhattacharyya, Pooja, Cassaday, Ryan D, Cheng, Guang-Shing, Escobar, Zahra Kassamali, Ghiuzeli, Cristina, McCulloch, Denise J, Pergam, Steven A, Roychoudhury, Pavitra, Tverdek, Frank, Schiffer, Joshua T, Ford, Emily S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296060/
https://www.ncbi.nlm.nih.gov/pubmed/37383248
http://dx.doi.org/10.1093/ofid/ofad306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296060/
https://www.ncbi.nlm.nih.gov/pubmed/37383248
http://dx.doi.org/10.1093/ofid/ofad306

Ejemplares similares